Andreas Kjær

Andreas Kjær

Professor


  1. Published

    Simultaneous hyperpolarized 13C-Pyruvate MRI and 18F-FDG PET (HyperPET) in 10 dogs with cancer

    Borgwardt, H. G., Hansen, Adam Espe, Larsen, M. M. E., Rahbek, S., Henriksen, S. T., Johannesen, Helle Hjorth, Ardenkjær-Larsen, J. H., Kristensen, Annemarie T., Højgaard, Liselotte & Kjær, Andreas, Nov 2015, In: Journal of Nuclear Medicine. 56, 11, p. 1786-92 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Simultaneous hyperpolarized 13C-pyruvate MRI and 18F-FDG-PET in cancer (hyperPET): feasibility of a new imaging concept using a clinical PET/MRI scanner

    Borgwardt, H. G., Hansen, Adam Espe, Henriksen, S. T., Johannesen, Helle Hjorth, Ardenkjær-Larsen, J. H., Vignaud, A., Hansen, A. E., Børresen, Betina, Klausen, Thomas Levin, Wittekind, A. N., Gillings, N., Kristensen, Annemarie T., Clemmensen, Andreas Høeg, Højgaard, Liselotte & Kjær, Andreas, Jan 2015, In: American Journal of Nuclear Medicine and Molecular Imaging. 5, 1, p. 38-45 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Simultaneous imaging of hyperpolarized [1,4-13 C2 ]fumarate, [1-13 C]pyruvate and 18 F-FDG in a rat model of necrosis in a clinical PET/MR scanner

    Eldirdiri, A., Clemmensen, Andreas Høeg, Bowen, S., Kjær, Andreas & Ardenkjaer-Larsen, J. H., Dec 2017, In: N M R in Biomedicine. 30, 12, 9 p., e3803.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Single Particle and PET-based Platform for Identifying Optimal Plasmonic Nano-Heaters for Photothermal Cancer Therapy

    Jørgensen, Jesper Tranekjær, Nørregaard, K., Tian, P., Bendix, Poul Martin, Kjær, Andreas & Oddershede, L. B., 2016, In: Scientific Reports. 6, 10 p., 30076.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Site-Specific 64Cu Labeling of the Serine Protease, Active Site Inhibited Factor Seven Azide (FVIIai-N3), Using Copper Free Click Chemistry

    Jeppesen, T. E., Kristensen, L. K., Nielsen, Carsten Haagen, Petersen, L. C., Kristensen, J. B., Behrens, C., Madsen, J. & Kjær, Andreas, 2018, In: Bioconjugate Chemistry. 29, 1, p. 117-125 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Site-specifically labeled 89Zr-DFO-trastuzumab improves immuno-reactivity and tumor uptake for immuno-PET in a subcutaneous HER2-positive xenograft mouse model

    Kristensen, L. K., Christensen, C., Jensen, M. M., Agnew, B. J., Schjöth-Frydendahl, C., Kjær, Andreas & Nielsen, Carsten Haagen, 2019, In: Theranostics. 9, 15, p. 4409-4420

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Small animal positron emission tomography imaging and in vivo studies of atherosclerosis

    Hag, Anne Mette Fisker, Ripa, Rasmus Sejersten, Pedersen, S. F., Bodholdt, R. P. & Kjær, Andreas, May 2013, In: Clinical Physiology and Functional Imaging. 33, 3, p. 173-85 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case-control study

    Knudsen, A., Møller, H. J., Katzenstein, T. L., Gerstoft, Jan, Obel, Niels, Kronborg, Gitte, Benfield, T., Kjær, Andreas & Lebech, A., 21 May 2013, In: B M C Infectious Diseases. 13, p. 230

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV-1-infected patients: a nested case-control study

    Rasmussen, L. J. H., Knudsen, A., Katzenstein, T. L., Gerstoft, Jan, Obel, Niels, Jørgensen, Niklas Rye, Kronborg, Gitte, Benfield, Thomas, Kjær, Andreas, Eugen-Olsen, J. & Lebech, Anne-Mette, May 2016, In: HIV Medicine. 17, 5, p. 350-7 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Soluble urokinase plasminogen activator receptor (suPAR) is lower in disease-free patients but cannot rule out incident disease in patients with suspected cancer

    Rasmussen, L. J. H., Schultz, M., Iversen, Kasper, Eugen-Olsen, J., Helms, Morten, David, K., Kjær, Andreas, Lebech, Anne-Mette & Kronborg, Gitte, 2020, In: Clinical Biochemistry. 84, p. 31-37

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 13402